RL
RLAY
Relay Therapeutics
$18.87
1M -6.0%
3M +32.5%
YTD +130.7%
as of 2026-09-11
✓Watchlist
↑↓ next ticker
· ⌘+↑↓ or scroll to zoom
· ←→ pan · 0 reset
▲ buy
▼ sell · size ≈ trade size
· ─ moving averages ·
click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Mean reversion
Neutral — RSI(2) at 51
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.26%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.56 -0.3% · Seasonal tilt (5y) -0.1%
$55M/day volume
69% volatility
+365% 1-year
-71% from ATH
52-week range · 86% of the way up · -11% from the high
$3.88$21.27
Congressional trades in RLAY
Full tracker →
1 member · 0 buys / 1 sells
· $1K–$15K disclosed · latest filing Aug 13, 2023.
| SELL |
DG Daniel Goldman
· traded Jul 12, 2023 |
$1K–$15K |
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.